Accéder au contenu
Merck
Toutes les photos(2)

Key Documents

View All Documentation

294837

Sigma-Aldrich

Chlorure d'hydrogène solution

1.0 M in diethyl ether

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(2)

About This Item

Formule empirique (notation de Hill):
HCl
Numéro CAS:
7647-01-0
Poids moléculaire :
36.46
Numéro MDL:
MFCD00011324
Code UNSPSC :
12352301
ID de substance PubChem :
329753358
Nomenclature NACRES :
NA.21

Forme

liquid

Niveau de qualité

100

Concentration

0.95-1.10 M (with NaOH, titration)
1.0 M in diethyl ether

Densité

0.731 g/mL at 25 °C

Température de stockage

2-8°C

Chaîne SMILES 

Cl

InChI

1S/ClH/h1H

Clé InChI

VEXZGXHMUGYJMC-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

Hydrogen chloride solution (1.0 M in diethyl ether) is generally prepared by passing HCl gas through diethyl ether solvent. It is suitable for air/moisture-sensitive reactions.

Application

Hydrogen chloride solution (1.0 M in diethyl ether) can be used in the synthesis of molybdenum adamantylimido and t-butylimido alkylidene chloride complexes in the presence of PPh2Me. It is also used in some cyclization reactions, for example, in the cyclization of oxadiazole derivatives from corresponding thiosemicarbazides.

Pictogrammes

FlameCorrosionExclamation mark
GHS02,GHS05,GHS07

Mention d'avertissement

Danger

Mentions de danger

H225,H290,H302,H336

Classification des risques

Acute Tox. 4 Oral - Flam. Liq. 2 - Met. Corr. 1 - STOT SE 3

Organes cibles

Central nervous system

Risques supp

EUH019,EUH066

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

-40.0 °F - closed cup

Point d'éclair (°C)

-40 °C - closed cup

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to
Mahsa Sadeghi et al.
British journal of pharmacology, 172(2), 460-468 (2014-01-01)
Tapentadol is a novel analgesic that combines moderate μ-opioid receptor agonism and noradrenaline reuptake inhibition in a single molecule. Both mechanisms of action are involved in producing analgesia; however, the potency and efficacy of tapentadol in individual neurons has not
Xuan Zhang et al.
Nanomedicine : nanotechnology, biology, and medicine, 11(6), 1365-1375 (2015-04-19)
Intratumoral injection of ultra-small gold nanoparticles (AuNPs) conjugated to doxorubicin (Au-Dox) is effective against both murine B16 and human SK-MEL-28 tumors in mice. Au-Dox suppresses growth of B16 tumors in immunocompetent mice by >70% for at least 19 days. In
Ann Brinkmalm et al.
Molecular neurodegeneration, 9, 53-53 (2014-11-25)
Synaptic degeneration is an early pathogenic event in Alzheimer's disease, associated with cognitive impairment and disease progression. Cerebrospinal fluid biomarkers reflecting synaptic integrity would be highly valuable tools to monitor synaptic degeneration directly in patients. We previously showed that synaptic
Christine Egger et al.
Journal of magnetic resonance imaging : JMRI, 41(3), 829-840 (2014-03-07)
To assess with magnetic resonance imaging (MRI) adriamycin-induced nephropathy in living rats, an established model for proteinuric renal disease was used. Functional information of contrast agent clearance was obtained with dynamic contrast-enhanced (DCE) imaging following intravenous Gd-DOTA administration. Perfusion data
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique